Vasostatin Inhibits VEGF-Induced Endothelial Cell Proliferation, Tube Formation and Induces Cell Apoptosis under Oxygen Deprivation
Open Access
- 9 April 2014
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 15 (4) , 6019-6030
Abstract
Anti-angiogenesis treatment has been a promising new form of cancer therapy. Endothelial cells are critical for vascular homeostasis and play important roles in angiogenesis, vascular and tissue remodeling. Vasostatin, the 180 amino acid N-terminal fragment of the calreticulin protein, is reported to be a potent endogenous inhibitor of angiogenesis, suppressing tumor growth. However, the mechanism of these effects has not been sufficiently investigated. This study was performed to investigate the possible mechanism of vasostatin effects on primary cultured human umbilical vein endothelial cells (HUVEC). We found that vasostatin could inhibit the cell viability of HUVEC and induce cell apoptosis through mitochondrial pathways via activation of caspase-3 under oxygen deprivation conditions. Meanwhile, vasostatin also inhibited vascular endothelial growth factor-induced proliferation and tube formation of HUVEC. The possible mechanism of vasostatin-inhibited proliferation of HUVEC could be through down-regulation of endothelial nitric oxide synthase. These findings suggest that vasostatin could regulate endothelial cell function and might be used in anti-angiogenesis treatment.Keywords
This publication has 36 references indexed in Scilit:
- Anti-angiogenesis therapy in cancer: Current challenges and future perspectivesCancer Letters, 2012
- Tumor Endothelial CellsCold Spring Harbor Perspectives in Medicine, 2011
- Endothelial nitric oxide synthase controls the expression of the angiogenesis inhibitor thrombospondin 2Proceedings of the National Academy of Sciences, 2011
- Endothelial Cell Migration During AngiogenesisCirculation Research, 2007
- Optical Imaging of the Adoptive Transfer of Human Endothelial Cells in Mice Using Anti-Human CD31 Monoclonal AntibodyPharmaceutical Research, 2007
- Targeting the Vascular Endothelial Growth Factor Pathway in the Treatment of Human MalignancyImmunological Investigations, 2007
- Novel Anti-Inflammatory Properties of the Angiogenesis Inhibitor VasostatinJournal of Investigative Dermatology, 2007
- Antagonistes de Bcl-2, thérapies anticancéreuses alternativesBiologie Aujourd'hui, 2005
- Proangiogenic activity of beta-carotene is coupled with the activation of endothelial cell chemotaxisBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2004
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996